医学
肺结核
儿科
残余物
重症监护医学
剩余风险
内科学
梅德林
结核分枝杆菌
肺外结核
作者
Chi Zhang,Qi Wang,Junwei Zhang,Yuanhua Yang,Juanni Gong
出处
期刊:The European respiratory journal
[European Respiratory Society]
日期:2026-11-01
卷期号:68 (5): 2601294-2601294
标识
DOI:10.1183/13993003.01294-2026
摘要
Extract We read with great interest the timely and important study by Liu et al. [1], which provides a comprehensive global assessment of drug-resistant (DR) tuberculosis (TB) in children. The authors should be congratulated for moving paediatric DR-TB from the periphery of adult-focused estimates to the centre of analysis, with stratification by resistance phenotype, age, sex, sociodemographic development and HIV status. Their findings provide a valuable framework for understanding paediatric multidrug-resistant (MDR)/rifampicin-resistant (RR) TB and extensively drug-resistant (XDR) TB as a distinct residual burden in the End TB era.
科研通智能强力驱动
Strongly Powered by AbleSci AI